Diosuxentan is an investigational new drug that is being developed by Biocity Biopharmaceutics for the treatment of diabetic nephropathy. It is an endothelin A receptor antagonist.

From Wikipedia (CC BY-SA 4.0).

Diosuxentan is an investigational new drug that is being developed by Biocity Biopharmaceutics for the treatment of diabetic nephropathy. It is an endothelin A receptor antagonist.

Overview

Diosuxentan is an investigational new drug that is being developed by Biocity Biopharmaceutics for the treatment of diabetic nephropathy. It is an endothelin A receptor antagonist.

From Wikipedia (CC BY-SA 4.0).

diosuxentan across IJR

Ask IJR about diosuxentan Create in Studio Build a game Watch videos